156 related articles for article (PubMed ID: 17566238)
1. [Conflict of interest: none stated].
Gulmann NC
Ugeskr Laeger; 2007 May; 169(21):2039; author reply 2039. PubMed ID: 17566238
[No Abstract] [Full Text] [Related]
2. PLoS Medicine and the pharmaceutical industry.
PLoS Medicine Editors
PLoS Med; 2006 Jul; 3(7):e329. PubMed ID: 17149970
[TBL] [Abstract][Full Text] [Related]
3. [Transparency, reliability and conflict of interest].
Lunde IM; Gøtzsche PC
Ugeskr Laeger; 2011 Aug; 173(33):1989. PubMed ID: 21969951
[No Abstract] [Full Text] [Related]
4. Regarding 'Is PHARMAC's sole-supply tendering policy harming the health of New Zealanders?' editorial.
Gray B
N Z Med J; 2005 May; 118(1215):U1481; discussion U1481. PubMed ID: 15915196
[No Abstract] [Full Text] [Related]
5. Bold suggestion by Smith.
Cohen D
PLoS Med; 2005 Jul; 2(7):e226. PubMed ID: 16033320
[No Abstract] [Full Text] [Related]
6. Regarding Pippa MacKay's editorial: the NZMA Chairman's response.
Boswell R
N Z Med J; 2005 Jun; 118(1216):U1510. PubMed ID: 15937538
[No Abstract] [Full Text] [Related]
7. Tackling conflicts of interest. Industry tie may be benchmark of quality.
van Lent M; Out HJ
BMJ; 2011 Sep; 343():d5607. PubMed ID: 21896592
[No Abstract] [Full Text] [Related]
8. Little fish are less likely to take the bait.
Marcovitch H
PLoS Med; 2005 Jul; 2(7):e221. PubMed ID: 16033315
[No Abstract] [Full Text] [Related]
9. Focus on the funding and production of evidence rather than its publication.
Sheldon T
PLoS Med; 2005 Jul; 2(7):e222. PubMed ID: 16033316
[No Abstract] [Full Text] [Related]
10. [Contact to the Danish Committees on Scientific Dishonesty is the logical step].
Jensen IS
Ugeskr Laeger; 2009 Apr; 171(15):1308; author reply 1308. PubMed ID: 19422162
[No Abstract] [Full Text] [Related]
11. [Who is to be trusted? On press reporters' assignments and agendas].
Nyrén O
Lakartidningen; 2002 Dec; 99(50):5110-2. PubMed ID: 12572305
[No Abstract] [Full Text] [Related]
12. [Why this arrogance, Josef Milerad?].
Olin GA
Lakartidningen; 2003 Jan; 100(4):254-5. PubMed ID: 12580016
[No Abstract] [Full Text] [Related]
13. Tackling conflicts of interest. Ban against industry ties introduces bias and obscures whole view.
McCay L
BMJ; 2011 Sep; 343():d5602. PubMed ID: 21896590
[No Abstract] [Full Text] [Related]
14. If it's too good to be true, it probably is.
Kennedy MS
Am J Nurs; 2009 Dec; 109(12):7. PubMed ID: 19935148
[No Abstract] [Full Text] [Related]
15. [Shoot the messenger!--or the art of changing the subject of conversation].
Zackrisson B
Lakartidningen; 2003 Jan; 100(4):252-3. PubMed ID: 12580015
[No Abstract] [Full Text] [Related]
16. [A reply to Per Gunnar Holmgren: Is the placement of advertising in the Dagens Medicin random or controlled?].
Milerad J
Lakartidningen; 2003 Jan; 100(4):249-50. PubMed ID: 12580013
[No Abstract] [Full Text] [Related]
17. [Merck & Co: Lakartidningen is wrong about us].
Ringart T
Lakartidningen; 2008 Nov 12-18; 105(46):3358; author reply 3358-9. PubMed ID: 19062629
[No Abstract] [Full Text] [Related]
18. [Ghostwriting].
Haug C
Tidsskr Nor Laegeforen; 2008 May; 128(9):1039. PubMed ID: 18451881
[No Abstract] [Full Text] [Related]
19. Tackling conflicts of interest. American Family Physician has prohibited using editorialists with industry ties for over 20 years.
Siwek J
BMJ; 2011 Sep; 343():d5651. PubMed ID: 21896601
[No Abstract] [Full Text] [Related]
20. [The journals must honestly tell who is doing the job].
Bergström R
Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
[No Abstract] [Full Text] [Related]
[Next] [New Search]
